ArticleIranian journal of basic medical sciences2022

Epigallocatechin-3-gallate alleviates type 2 diabetes mellitus via β-cell function improvement and insulin resistance reduction.

Tiantian Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.